The research group “Cell Signalling and Therapeutic Targets in Cancer” of the Valdecilla Health Research Institute Foundation (IDIVAL) and the Marqués de Valdecilla University Hospital have genetically identified a new variant of the autistic spectrum in a pediatric patient by applying techniques of massive sequencing. Known as the ADNP syndrome, the identification of this variant […]
Dr. Marcos López Hoyos, Head of the Immunology Service of the Marqués de Valdecilla University Hospital (Santander, Cantabria) and principal investigator of the Transplant and Autoimmunity IDIVAL group, has been proclaimed incoming President of the SEI (Spanish Society of Immunology). The result of the elections was 100 votes in favor and 5 votes blank. The […]
This UIMP meeting, co-organized by the Health Institute Carlos III and IDIVAL is dedicated to Responsible Research and Innovation (RRI). The RRI requires participation from broad deliberation forums that reinforce the democratic spirit of our society in the field of research and innovation. Its own generation needs of starting points based on open and transparent […]
Carried out in collaboration with CIC bioGUNE, this study promotes the development of a therapy that attenuates liver injury and slows the progression of these pathologies. A research project of the digestive pathology group of the HUMV and the IDIVAL that paves the way for the development of a therapy that attenuates liver injury and […]
What is COST? COST (Cooperation in Science and Technology) is the longest-running European framework supporting transnational cooperation among researchers, engineers and scholars across Europe. Together with Horizon 2020 it is one of the most important pillars of the promotion of research cooperation in Europe and therefore an essential component of the European Research Area (ERA). […]
The next conference of the Santander Biomedical Lectures program organized by IDIVAL, the University of Cantabria and IBBTEC will take place on the 30th of May. The session will be given by Guadalupe Garcia-Tsao and will be about: “Regression of cirrhosis and portal hypertension. Is it a reality?”. Guadalupe Garcia-Tsao, M.D. is Professor of Medicine […]
The CRIS Cancer Foundation opens the application deadline for the CRIS Research Excellence Programs on June 1. – CRIS Research Talent Program • Objective: Training and stabilization of the profile of the medical researcher in Spanish public institutions. • Duration: 5 years • Provision: € 80,000 per year (€ 400,000 in total). • 2 are […]
The next conference of the Santander Biomedical Lectures program organized by IDIVAL, the University of Cantabria and IBBTEC will take place on the 25th of April. The session will be given by Pier Luigi Meroni and will be about: “Updating of APS pathophysiology: does it impact on our clinical management?”. Dr. Pier Luigi Meroni graduated […]
During 2018 IDIVAL processed 9 patent applications, representing three times the number of applications with respect to the 2013 and previous annuities. Factors such as the promotion of the innovative culture, the certification of the institute by the UNE 166: 002, as well as the incorporation of new specific aids of innovation and technological development […]
The next conference of the Santander Biomedical Lectures program organized by IDIVAL, the University of Cantabria and IBBTEC will take place on the 28th of March. The session will be given by Gelareh Zadeh and will be about: “Epigenetics in neuro-oncology”. Dr. Gelareh Zadeh completed her neurosurgery training, and is a PhD in brain tumor […]
